The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Mon., Oct. 3, 1:47 PM

Slide #9. First Wave BioPharma, Inc. (NASDAQ:FWBI) 1 for 30 Reverse Split

Announced: 8/25/2022
Stock Split: 1 for 30
Record Date: 8/25/2022
Pay Date: 8/26/2022
FWBI Optionable?: No

First Wave BioPharma engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Co. is focused on developing its drug product candidate, MS1819, a yeast derived recombinant lipase for exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis. Co.'s b-lactamase program focuses on products with an enzymatic combination of bacterial origin for the prevention of hospital-acquired infections and antibiotic-associated diarrhea by resistant bacterial strains induced by parenteral administration of several antibiotic classes. Co.'s compounds in pre-clinical development include: AZX1101 and AZX1103.
FWBI Detailed Information Page & Split History »

Company Name: 
First Wave BioPharma Inc
Number of ETFs Holding FWBI: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the FWBI Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree FWBI Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.00 out of 4)
21st percentile
(ranked lower than approx. 79% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.